Clover Health Investments, Corp.

NasdaqGS:CLOV Stock Report

Market Cap: US$2.3b

Clover Health Investments Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CLOV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Jul 26SellUS$21,622Clay ThorntonIndividual4,630US$4.67
15 Jul 26SellUS$49,124Karen SoaresIndividual10,519US$4.67
15 Jul 26SellUS$61,266Jamie ReynosoIndividual13,119US$4.67
15 Jul 26SellUS$113,084Conrad WaiIndividual24,215US$4.67
15 Jul 26SellUS$292,860Andrew ToyIndividual62,711US$4.67
06 Jul 26SellUS$32,765Jamie ReynosoIndividual6,229US$5.26
01 Jul 26SellUS$1,667,692Andrew ToyIndividual313,476US$5.32
16 Jun 26SellUS$58,816Joseph OldakowskiIndividual12,102US$4.86
15 Jun 26SellUS$29,274Jamie ReynosoIndividual6,350US$4.61
15 Jun 26SellUS$21,579Karen SoaresIndividual4,681US$4.61
18 May 26SellUS$229,687Carladenise EdwardsIndividual67,160US$3.42
13 May 26SellUS$345,097Brady PriestIndividual98,039US$3.52
04 Mar 26SellUS$379,750Brady PriestIndividual175,000US$2.17
13 Aug 25BuyUS$68,755Anna LoengardIndividual26,500US$2.60
08 Aug 25BuyUS$998,997Vivek GaripalliIndividual446,980US$2.24

Insider Trading Volume

Insider Buying: CLOV insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLOV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders114,639,49521.8%
Institutions128,418,24024.4%
General Public283,626,58953.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.8%
Vivek Garipalli
93,584,903US$406.2m1.34%no data
6.05%
BlackRock, Inc.
31,851,512US$138.2m-1.33%no data
3.22%
Vanguard Capital Management, LLC
16,982,073US$73.7m0%no data
1.91%
Geode Capital Management, LLC
10,055,510US$43.6m2.7%no data
1.82%
State Street Global Advisors, Inc.
9,559,889US$41.5m2.57%no data
1.16%
Andrew Toy
6,130,710US$26.6m14.8%no data
1.01%
Charles Schwab Investment Management, Inc.
5,300,475US$23.0m0%no data
0.71%
The PNC Financial Services Group, Inc.
3,763,934US$16.3m0%0.01%
0.7%
Vanguard Portfolio Management, LLC
3,696,437US$16.0m0%no data
0.65%
Dimensional Fund Advisors LP
3,417,866US$14.8m-5.96%no data
0.65%
Renaissance Technologies LLC
3,401,541US$14.8m-24.3%0.02%
0.63%
Northern Trust Global Investments
3,306,575US$14.4m4.03%no data
0.53%
Jamie Reynoso
2,814,640US$12.2m115%no data
0.53%
Vanguard Fiduciary Trust Company
2,806,210US$12.2m3.71%no data
0.48%
Conrad Wai
2,535,755US$11.0m36.2%no data
0.47%
UBS Asset Management AG
2,449,594US$10.6m16.9%no data
0.4%
Morgan Stanley
2,098,434US$9.1m-16.4%no data
0.39%
Brady Priest
2,040,222US$8.9m34.3%no data
0.36%
Citadel Advisors LLC
1,878,048US$8.2m63.6%0.01%
0.33%
The Goldman Sachs Group, Inc.
1,739,840US$7.6m0%no data
0.32%
Hudson River Trading LLC
1,667,691US$7.2m0%0.02%
0.3%
Peter Kuipers
1,578,967US$6.9m20.7%no data
0.29%
Karen Soares
1,505,522US$6.5m25.5%no data
0.25%
GMT Capital Corp.
1,305,200US$5.7m0%0.16%
0.23%
Clay Thornton
1,212,954US$5.3m272%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/31 03:56
End of Day Share Price 2026/07/31 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clover Health Investments, Corp. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin FischbeckBofA Global Research
Richard CloseCanaccord Genuity
Jason CassorlaCitigroup Inc